Here are three points:
1. VertiFlex proposes to raise a total of $45.7 million in funding.
2. The company’s Superion Interspinous Spacer device received pre-market approval from the FDA last year to treat moderate lumber spinal stenosis.
3. VertiFlex has raised $93 million in funding rounds since 2007.
More articles on devices:
Amedica adds 2nd generational cervical system—5 highlights
SeaSpine, K2M, Smith & Nephew & more: 16 key notes
Is the Johnson & Johnson job cut an ominous sight for the medical device industry? 5 key thoughts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
